Amneal Pharmaceuticals (AMRX)
(Delayed Data from NSDQ)
$6.66 USD
+0.19 (2.94%)
Updated May 10, 2024 04:00 PM ET
After-Market: $6.65 -0.01 (-0.15%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (94 out of 251)Zacks Sector Rank
Top 25% (4 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.80 | 1.52 | 9.99 |
Current Quarter Estimate | 0.14 | -2.04 | 57.00 |
Year Ago Quarter Estimate | 0.19 | -0.59 | 52.54 |
Next Quarter Estimate | 0.14 | -2.00 | 61.00 |
Next Year Estimate | 0.59 | 6.92 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -10.94 | 11.80 | 15.67 |
Next Year | 3.51 | 15.40 | 9.31 |
Last 5 Years | -2.30 | 4.90 | 8.10 |
Next 5 Years | NA | 22.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 10.09 | -5.88 |
Price/Book (MRQ) | NA | 1.91 |
Price/Cash Flow (MRFY) | 4.93 | 9.59 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -6.76% | 0.82% |
Return on Equity (TTM) | 234.06% | -24.69% |
Debt to Equity (MRQ) | -38.03 | 0.04 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.